Paxil Risks, Regulatory Timeline, and GlaxoSmithKline Litigation

Prenatal Health and Paxil Risks

  • Maternal choices during pregnancy—including nutrition, physical activity, and medication—directly influence fetal development.

  • Devon Aguilar reached a healthy weight of nine pounds at five weeks after Gina Aguilar monitored exercise and avoided contraindicated medications.

  • Paxil is an antidepressant drug known to cause serious, life-threatening birth defects when taken during pregnancy.

  • Birth Dfects:

1) Holes in Heart

2) Lung Df

Regulatory Timeline and GlaxoSmithKline Litigation

  • 1992: Paxil was first introduced to the market.

  • 2005: Following 13 years on the market without explicit alerts, manufacturer GlaxoSmithKline was required to place a label warning regarding fetal dangers when the drug is taken early in pregnancy.

  • June 2010: Over 200 birth defect lawsuits had been filed involving the drug.

  • Legal Damages and Evidence: A family was awarded $2,500,000 after their infant was born with three holes in his heart; trial evidence revealed GlaxoSmithKline had considered concealing the medication's potential to cause birth defects.

  • Advocacy Context: Commentary and case monitoring provided by Jody Sinclair, spokesperson for Jim Adler and Associates.